CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, microarrays comparing CML CD34+ cells with normal CD34+ cells have revealed Bcr–Abl-induced functional alterations, such as increased cell-cycle and proteasome activity (296).